Advertisement
YOU ARE HERE: LAT HomeCollectionsMen Health
IN THE NEWS

Men Health

CALIFORNIA | LOCAL
February 26, 1998 | Times medical writer Thomas H. Maugh II
The drug Proscar has been shown for the first time to reduce the need for surgery to treat enlarged prostate glands. In a study of 3,040 men with prostate enlargement reported today in the New England Journal of Medicine, only 5% of those who took Proscar required prostate-reduction surgery compared to 10% of those who got dummy pills. Proscar, known generically as finasteride, is one of the most widely prescribed prostate drugs.
Advertisement
NEWS
January 14, 1998 | From Times Wire Reports
Black men are two to three times more likely to die of prostate cancer than white men, and doctors can't explain why or reduce the risks. Calling the figures "a disgraceful tragedy," the American Cancer Society and the group 100 Black Men of America urged a national attack on prostate cancer. At the top of the agenda is increasing federal research.
NEWS
January 23, 1998 | From Associated Press
A quarter of men have high levels of a growth protein linked to a greater likelihood of prostate cancer, says a new study that may point scientists toward ways to reduce the incidence of the cancer. Dr. Michael Pollak of McGill University, who coauthored the study with Harvard University scientists, said if the new research is confirmed, doctors may one day use the protein to better predict which men will one day get cancer.
CALIFORNIA | LOCAL
June 8, 2000 | JULIE MARQUIS, TIMES HEALTH WRITER
Los Angeles County public health officials announced Wednesday that an outbreak of syphilis primarily among gay men appears to be subsiding. Dr. James Haughton, medical director of public health for Los Angeles County, said that despite increased surveillance and testing, just one new case of syphilis has been reported in the last six weeks. "We are hoping the outbreak has peaked and is waning now," he said.
HEALTH
April 23, 2001 | JANE E. ALLEN, TIMES HEALTH WRITER
Al Lakin says he was thinking of his two teenage sons when he volunteered to take part in two clinical studies of male hormonal contraceptives. "I look at the options I had at their age," said Lakin, 48. "It was to keep my pants zipped." Lakin, a computer software consultant from Tarzana, believes men should assume more responsibility for the consequences of sex. And that by doing so, they provide their partners with more options for preventing pregnancy.
NEWS
September 16, 1998 | From Times Wire Reports
A study raised questions about a widely used prostate cancer radiation therapy in cases where there is a high risk the disease will spread. Researchers at Harvard Medical School said a nearly four-year study involving 1,872 men found poorer outcomes for high-risk patients treated by implanting radioactive "seeds" in the gland, compared with those treated more aggressively. The study, published in Chicago in the Journal of the American Medical Assn.
NEWS
March 7, 1997
"It's one of the worst cancers to die of. It's characterized by widespread bone pain, which is almost an intractable pain for us to deal with, and the terminal phases last a year or two or even longer." --Thomas E. Ahlering MD, chief of urology, UC Irvine College of Medicine "Search for the first time the word 'prostate' was mentioned in your newspaper. It was not before 1960 or '70, I'll tell you that, even though it was a major disease in this country. No one talked about this." --Donald F.
NEWS
January 1, 1997 | From Times Staff and Wire Reports
A new blood test holds promise of predicting possible cases of prostate cancer up to 10 years before the disease can be diagnosed, a six-year jump on current methods, scientists reported. The new test involves a different way of monitoring the enzyme PSA, or prostate specific antigen, in a man's blood, according to researchers at the National Institute on Aging and the Johns Hopkins University School of Medicine.
NEWS
August 21, 1996 | From Associated Press
A little-known form of "bad" cholesterol that doctors cannot yet measure reliably may cause early heart disease just as often as its better-known cousins, a study suggests. The lesser-known culprit, called lipoprotein(a), may lurk in dangerously high levels in the blood of people whose other cholesterol levels appear normal on routine tests, researchers say.
Los Angeles Times Articles
|